Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2415 of 6351
-
Gut bacteria may lift mood in bipolar depression
Symptom relief CompletedBipolar Disorder (BD) is highly incapacitating and associated with premature mortality. Depressive symptoms and episodes are the most frequent cause of disability in subjects with BD and over half of patients do not respond adequately to approved treatments for this condition, sh…
Sponsor: University of Sao Paulo • Aim: Symptom relief
Last updated Jun 27, 2026 12:32 UTC
-
CBD drug shows promise for stubborn heart pain
Symptom relief CompletedPatients with recurrent pericarditis who are refractory or intolerant to current therapeutic management options or who require long-term administration of corticosteroids to control their disease are particularly challenging to manage. The pathogenesis of pericarditis involves th…
Phase 2 • Sponsor: Cardiol Therapeutics Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 07:55 UTC
-
HIV hiding spots revealed in treatment pause study
Knowledge-focused Recruiting nowBackground: Human immunodeficiency virus (HIV) infects CD4 T cells. There is no cure for HIV. People with HIV need to take daily medications called antiretroviral therapy (ART) to control their infection. ART stops HIV from infecting cells, but HIV does not go away. Some infecte…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
New antibody PRL3-Zumab tested against advanced cancers
Disease control Recruiting nowThis is a Multi-Center, Phase II/III, open-label, single dose level (6 mg/kg) basket trial of PRL3-zumab monotherapy in solid cancer patients. The study will consist of a Screening Period (Day - 14 to Day -1) for completion of all screening assessments before the first administr…
Phase 2/3 • Sponsor: Intra-IMMUSG Pte Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Can a new hyaluronic acid filler smooth wrinkles and add volume?
Symptom relief Recruiting nowEvaluation of the safety and performance of the investigational device in its three concentrations for cheek and lips augmentation and correction of the nasolabial folds, assuming that the performance of the product will be demonstrated based on the responder rates observed compa…
Sponsor: Hallura Ltd. • Aim: Symptom relief
Last updated Aug 15, 2026 00:00 UTC
-
New eczema drug cibinqo under Real-World safety review in korea
Disease control Recruiting nowThe purpose of this non-interventional study is to learn about the safety and effectivness of Cibinqo Tablet for the possible treatment of atopic dermatitis (AD). AD is a long-lasting itchy red rash, caused by a skin reaction. This study is seeking participants who: 1. Are pat…
Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Could a common diabetes drug ease Parkinson's symptoms?
Disease control CompletedParkinson's disease (PD) is one of the most common neurodegenerative diseases characterized by the progressive loss of dopaminergic (DA) neurons in the substantia nigra compacta (SNc) and aggregation of Lewy bodies in neurons. Although aging, oxidative damage and neuroinflammatio…
Phase 2 • Sponsor: Tanta University • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New gout pill aims to stop flare pain in 3 days
Symptom relief Recruiting nowThe purpose of this trial is to investigate the efficacy and safety of dapansutrile (OLT1177®) tablets in subjects with an acute gout flare.
Phase 2/3 • Sponsor: Olatec Therapeutics LLC • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
Robot trainer aims to keep seniors on their feet during hospital stays
Disease control OngoingThis study aims to address if robot assisted physical training can prevent functional decline during acute hospitalisation in older geriatric patients. Design: blinded RCT. Patients: n = 488. Primary outcome is functional decline, assessed by Barthel-Index and 30s chair stand te…
Sponsor: Odense University Hospital • Aim: Disease control
Last updated Jun 26, 2026 14:52 UTC
-
New hope for advanced tumors: BL-M07D1 enters human testing
Disease control Recruiting nowEvaluation of BL-M07D1 for injection in Phase I clinical study of safety, tolerability, pharmacokinetic Characteristics, and initial efficacy in patients with locally advanced or metastatic digestive tract tumors and other solid tumors.
Phase 1 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Can a breathing gadget curb addiction cravings?
Disease control CompletedHeart rate variability biofeedback (HRVB) is an biobehavioral intervention involving rhythmic breathing at resonance frequency that stimulates cardiovascular regulatory systems to help individuals better regulate affect and bolster cognitive control. This intervention has already…
Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Can a simple toolkit make telemedicine work for burn emergencies?
Knowledge-focused Recruiting nowThe study team will use implementation science to accelerate the uptake of teleconsultationfor burn patients by 1) examining the relationships between clinician perceptions of acceptability, feasibility, intention to use, and actual use of burn teleconsultation 2) identifying the…
Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Memory tricks may boost PTSD therapy success
Symptom relief Recruiting nowThe efficacy of psychological interventions for posttraumatic stress disorder (PTSD) is likely limited by the difficulty participants have learning and remembering important therapy content. Accordingly, the present study will examine the utility of integrating a Memory Support (…
Sponsor: Boston University • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
New diabetes combo pill shows promise in Late-Stage trial
Disease control CompletedA multicenter, randomized, double-blind, placebo-controlled, parallel, phase Ⅲ study to evaluate the efficacy and safety of JW0201 added on in patients with type 2 diabetes mellitus who have inadequate glycemic control with C2202 and C2203
Phase 3 • Sponsor: JW Pharmaceutical • Aim: Disease control
Last updated Jun 26, 2026 14:35 UTC
-
New drug trial offers hope for Hard-to-Treat cancers
Disease control Stopped earlyThis study will test the safety of a drug called PF-08046049/SGN-BB228 in participants with melanoma and other solid tumors that are hard to treat or have spread through the body. It will also study the side effects of this drug. A side effect is anything a drug does to the body …
Phase 1 • Sponsor: Seagen, a wholly owned subsidiary of Pfizer • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New study tests if adding a second drug boosts UC treatment
Disease control Recruiting nowThis multicenter retrospective comparative cohort study evaluated the real-world effectiveness and safety of upadacitinib plus vedolizumab compared with upadacitinib monotherapy during 8-week induction in adults with moderate-to-severe ulcerative colitis. Consecutive eligible pa…
Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
New study: ultrasound test may unlock hidden cause of infertility after C-Section
Knowledge-focused Recruiting nowThis study selected patients who underwent cesarean section and were scheduled to undergo Saline Infusion Sonohysterography (SIS) for evaluating the structure of the incision. Clinical characteristics and clinical symptoms were collected. Combined with hysteroscopy, MRI, conventi…
Sponsor: Tang-Du Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:39 UTC
-
Could ditching gluten ease two tough gut diseases?
Disease control OngoingPrimary sclerosing cholangitis (PSC) is a progressive disease of the biliary tree, which represents one of the most frequent indications for orthotopic liver transplantation (OLTx) in developed countries. There are several lines of evidence that dietary gluten/gliadin displays ch…
Sponsor: Institute for Clinical and Experimental Medicine • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Spine surgery secrets: opening angle may determine recovery
Disease control Recruiting nowThe aim of study was evaluated the relationship between the relevant evaluation indexes of cervical spine open-door surgery, prognosis and complication rate, and provided theoretical basis for personalized surgical program through multi-center retrospective clinical study
Sponsor: Xijing Hospital • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
Could a Low-Dose ketamine infusion beat MS fatigue?
Symptom relief OngoingThe proposed study is a single-center, phase II, randomized, double-blind, parallel-group, active-placebo-controlled trial of intravenous low-dose ketamine in patients with MS fatigue.
Phase 2 • Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Jun 27, 2026 12:38 UTC